Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion type Assertion NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_head.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion description "[Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_provenance.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion evidence source_evidence_literature NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_provenance.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion SIO_000772 19036101 NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_provenance.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion wasDerivedFrom befree-20140225 NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_provenance.
- NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_assertion wasGeneratedBy ECO_0000203 NP172266.RAU5dN3__8dYZlmH_Q0k2pxKIBgb5LCvvuiB0qnDbN94A130_provenance.